跳至主要内容
临床试验/EUCTR2014-001332-11-IE
EUCTR2014-001332-11-IE进行中(未招募)1 期

Aspirin for Optimising Pregnancy Outcome in Pregestational Diabetes: Pilot for The IRELAND Study (Investigating the Role of Early Low-dose Aspirin iN preexisting Diabetes) - Investigating the Role of Early Low-dose Aspirin iN preexisting Diabetes - IRELAND

Royal College of Surgeons0 个研究点目标入组 23 人开始时间: 2014年4月10日最近更新:
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
入组人数
23

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
Female

入选标准

  • Inclusion criteria
  • People who satisfy all of the following may be included in the study:
  • 1.All women with type I or type II diabetes of at least 6 months duration prior to conception.
  • 2.Ability to speak and read English
  • 3.Singleton pregnancy at <12 weeks’ gestational age with documented fetal cardiac activity
  • 4.Those willing to sign voluntarily a statement of informed consent to participate in the study.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 24
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Exclusion criteria
  • The following patients will be excluded from participation in the study:
  • 1.Aspirin hypersensitivity (prior bronchospasm/ urticarial/ angioedema with aspirin),
  • 2.Peptic ulcer disease
  • 3.Known bleeding diathesis
  • 4.Multifetal gestation
  • 5.Severe early-onset preeclampsia in a previous pregnancy
  • 6.Patient already on aspirin
  • 7.Age under 18 years
  • 8.Concurrent participation in another clinical trial

研究者

相似试验